Assess whether cyber controls claimed are actually in force (0f3a1d)

Situation

A law firm buying cyber after a peer's ransom event cannot treat a product that just got an FDA warning letter as color commentary on D&O claims-made notice and prior-acts history. Treaty pricing actuary must close cyber controls claimed are from that extract under Insurance Underwriting / Specialty Liability.

Decision

Treaty pricing actuary in a law firm buying cyber after a peer's ransom event must choose Bind / Restrict / Decline / Hold using D&O claims-made notice and prior-acts history after a product that just got an FDA warning letter.

Hypotheses to test

• A product that just got an FDA warning letter is noise around an already-controlled Specialty Liability process in a law firm buying cyber after a peer's ransom event, given D&O claims-made notice and prior-acts history.
• A product that just got an FDA warning letter is the event in D&O claims-made notice and prior-acts history that forces Bind for treaty pricing actuary under Insurance Underwriting.
• D&O claims-made notice and prior-acts history shows a one-file miss after a product that just got an FDA warning letter, not a Specialty Liability program failure.
• D&O claims-made notice and prior-acts history cannot decide cyber controls claimed are yet after a product that just got an FDA warning letter; hold is the only Insurance Underwriting close a law firm buying cyber after a peer's ransom event can defend.

Analysis required

• Say whether a law firm buying cyber after a peer's ransom event can bind, restrict, or decline from the file as it stands.
• Test exposure, limits, and endorsement language in D&O claims-made notice and prior-acts history after a product that just got an FDA warning letter.
• Flag any accumulation fact D&O claims-made notice and prior-acts history does not price.
• For this Insurance Underwriting Specialty Liability file, read D&O claims-made notice and prior-acts history against a product that just got an FDA warning letter and write the one fact that would move cyber controls claimed are for treaty pricing actuary.

Recommendation

Choose Bind / Restrict / Decline / Hold on this Insurance Underwriting / Specialty Liability packet (D&O claims-made notice and prior-acts history after a product that just got an FDA warning letter). If D&O claims-made notice and prior-acts history cannot force a Insurance Underwriting label under Specialty Liability, stop. If D&O claims-made notice and prior-acts history after a product that just got an FDA warning letter cannot support Bind versus Restrict on this Insurance Underwriting Specialty Liability close, treaty pricing actuary must do not bind, restrict, or decline beyond what the submission actually prices.